Manila Bulletin Online
Nav Bar   Saturday, January 27, 2007 Navigation Nav Bar
Feedback Archives Contact Us Advertise Subscribe Desktop Headlines
spacer
 
spacer
spacer
spacer
spacer
spacer
spacer



 
spacer
Pharma company launches info campaign on blood flow problem
spacer




The Department of Health (DoH) commended Otsuka Philippines Pharmaceutical Inc. for organizing the Improve Peripheral Arterial Disease (i-PAD) Awareness Campaign.

The project aims to aid doctors diagnose Peripheral Arterial Disease (PAD) among diabetic patients. It also aims to disseminate information about PAD among people who are at risk of the disease.

"Your objective of improving the quality of life of people with PAD is certainly commendable,’’ said Dr. Yolanda Oliveros, director of DoH National Center for Disease Prevention and Control in her letter addressed to Otsuka. "Government alone cannot do the job of reaching to all these patients, as such, your effort as a pharmaceutical industry doing your share in alleviating the sufferings of our people is very much welcome.’’

PAD is a problem with blood flow in the arteries due to the build-up of fatty deposits (atherosclerosis). Over time, the deposit builds up and blocks the smaller arteries first, such as in the legs.

When not enough blood is supplied to the muscle due to the blockage, a person will experience claudication. Claudication, which is the common complaint of people with PAD, is a discomfort that is sometimes described as a fatigue, a numbness, a cramping or may actually be a severe pain that occurs in leg muscles after walking a certain distance.

Diabetes and smoking are the strongest risk factors for PAD. Patients who are hypertensive and have high cholesterol levels are also prone to the disease.

Under i-PAD Awareness Campaign, patients can avail of free ABI (ankle brachial index) screening and monofilament testing for free. ABI screening is a patient-friendly, inexpensive technique that compares blood pressures between and the patient’s arms and ankles. The ABI test is a useful tool, as it not only provides clinicians with a means of identification of PAD, but also with information regarding the severity of PAD that can assist in guiding a treatment approach.

Once diagnosed, patients will be given Pletaal (cilostazol) samples, an anti-platelet drug which is also used to treat PAD. Studies have shown the diabetic and non-diabetic patients with PAD respond favorably to cilostazol. Patients are also given free patient footcare guide and other relevant materials.

Printer Friendly Version spacer Email to a friend
 

spacer
OTHER HEALTH NEWS
spacer
spacer
spacer
spacer
 

spacer




HOME | SUBSCRIBE | ADVERTISE | CONTACT US | SEARCH | ARCHIVE | FEEDBACK

FEATURES: MB WAP | MB Mobile Edition | Desktop Headlines

SECTIONS: MAIN | BUSINESS | OPINION & EDITORIAL | SPORTS | YOUTH & CAMPUS | ENTERTAINMENT | AGRICULTURE | INFOTECH | HEALTH | TOURISM | SOCIETY | METRO & NATIONAL | PROVINCIAL | D R I V E | SCHOOLS, COLLEGES AND UNIVERSITIES | WELL-BEING | TECHNEWS | TASTE | WEDDINGS | I | BOARD PASSERS | MOMS AND BABIES | BUSINESS AGENDA | SPACE | PICTURE PERFECT | ENVIRONMENT | 

LINKS: PHILIPPINE PANORAMA | TEMPO | CLASSIFIED ADS ONLINE | USER PRIVACY POLICY

Copyright © 2001-2005, Manila Bulletin. All Rights Reserved.

designed and developed by
Alchemy Solutions